SEARCH

SEARCH BY CITATION

References

  • 1
    Luteijn JM, Dolk H, Marnoch GJ. Differences in pandemic influenza vaccination policies for pregnant women in Europe. BMC Public Health2011;11:819.
  • 2
    Mackenzie IS, MacDonald TM, Shakir S, Dryburgh M, Mantay BJ, McDonnell P, et al.Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. Br J Clin Pharmacol2012;73:80111.
  • 3
    Omon E, Damase-Michel C, Hurault-Delanue C, Lacroix I, Montastruc JL, Oustric S, et al.Non-adjuvanted 2009 influenza A (H1N1) vaccine in pregnant women: the result of a French prospective descriptive study. Vaccine2001;29:964954.
  • 4
    Tavares F, Nazareth I, Monegal JS, Kolte I, Verstraeten T, Bauchau V. Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (200)) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine2011;29:635865.
  • 5
    Lin TH, Lin SY, Lin RI, Lin HC, Chiu TH, Cheng PJ, et al.AdimFlu-S® influenza A (H1N1) vaccine during pregnancy: the Taiwanese Pharmacovigilance Survey. Vaccine2012;30:26715.
  • 6
    Oppermann M, Fritzsche J, Weber-Schoendorfer C, Keller-Stanislawski B, Allignol A, Meister R, et al.A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine2012;30:444552.
  • 7
    Pasternak B, Svanström H, Mølgaard-Nielsen D, Krause TG, Emborg HD, Melbye M, et al.Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ2012;344:e2794.
  • 8
    Fell DB, Sprague AE, Liu N, Yasseen AS III, Wen SW, Smith G, et al.for Better Outcomes Registry & Network (BORN) Ontario. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am J Public Health2012;102:e3340.
  • 9
    Dlugacz Y, Fleischer A, Carney MT, Copperman N, Ahmed J, Ross Z, et al.2009 H1N1 vaccination by pregnant women during the 2009–2010 H1N1 influenza pandemic. Am J Obstet Gynecol2012;206:339.
  • 10
    van Lier A, Steens A, Ferreira JA, van der Maas NA, de Melker HE. Acceptance of vaccination during pregnancy: experience with 2009 influenza A (H1N1) in the Netherlands. Vaccine2012;30:28929.
  • 11
    Meharry PM, Colson ER, Grizas AP, Stiller R, Vázquex M. Reasons why women accept or reject the trivalent inactivated influenza vaccine (TIV) during pregnancy. Matern Child Health J2012; epub a head of print. Doi:10.1007/s10995-012-0957-3.
  • 12
    National Board of Health and Welfare. Centre for Epidemiology. The Swedish Medical Birth Register – a summary of content and quality. 2003. [http://www.socialstyrelsen.se/Publikationer2003/2003-112-3]. Last accessed 6 March 2012.
  • 13
    Källén B. A birth weight for gestational age standard based on data in the Swedish medical birth registry, 1985–1989. Eur J Epidemiol1995;11:6016.
  • 14
    Omer S, Godman D, Steinhoff MC, Rochat R, Klugman KP, Stoll B, et al.Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLOS Med2011;8:e1000441.
  • 15
    Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications. Eur J Clin Pharmacol2007;63:37581.
  • 16
    Lee JH, Romero R, Kim J-S, Topping V, Yoo W, Kusanovic JP, et al.A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d. PLoS ONE2011;6:e16806.
  • 17
    Christian LM, Iams JD, Porter K, Glaser R. Inflammatory responses to trivalent influenza vaccine among pregnant women. Vaccine2011;29:89827.